6NL-27357-73045
1 vaccination
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 242 / VA
- Registered
- 2021-08-04
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-04
Registered in v-safe
-
2021-08-04
Dose 1 — Pfizer-BioNTech
- 2021-08-04
-
2021-08-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-10
- 2021-08-11
-
2021-08-18
Survey response — day 14, dose 1MedDRA: Peripheral swelling — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen feet and legsMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-27
-
2021-09-01
Survey response — day 28, dose 1MedDRA: Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe migrainesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-10
- 2021-09-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-04 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 1
Symptoms: Swollen feet and legs
Release 9 — day 28, dose 1
Symptoms: Severe migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | ✓ | · | ✓ |
| SD | Peripheral swelling | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release